EPRX · Eupraxia Pharmaceuticals Inc.

$6.68 -0.69 (-9.31%) At close · Aug 28

Market Cap

$441.04M

66.07M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date	Event	Type
2026-07-30	Virtual KOL Event to Discuss Upper Endoscopies and EoE Patients - Understanding How EP-104GI Administration Fits Within Clinical Practice	Webcast
2026-06-03	Jefferies Global Healthcare Conference	Conference
2026-05-04	Virtual Investor Event at Digestive Disease Week 2026	Event
2026-04-21	2026 Bloom Burton & Co. Healthcare Investor Conference	Conference
2026-04-14	Raymond James Biotech Innovation Symposium	Event
2025-10-01	Webinar - Eupraxia Pharmaceuticals Announces Positive Data from Highest-Dose Cohort in the Ongoing RESOLVE Trial in Eosinophilic Esophagitis, and Plans for Expansion of EP-104GI Development Programs	Webcast
2025-09-09	H.C. Wainwright 27th Annual Global Investment Conference	Conference
2025-09-05	Cantor Global Healthcare Conference	Conference
2025-08-13	Canaccord 45th Annual Growth Conference	Conference
2025-05-14	Tribe Public Webinar Presentation and Q&A Event titled, “Hard To Swallow: An Underdiagnosed Condition Rising To Surface (EOE)	Presentation
2025-05-13	Radius Research - Investments is hosting Eupraxia Pharmaceuticals with CEO James Helliwell for a Live Webinar and Q&A	Event

Source: https://www.eupraxiapharma.com/investors/

Key facts CIK 1581178 CUSIP 29842P105 13F (30d) 68 filings 66 filers Visit website Investor relations